Literature DB >> 9883006

Hepatitis after alendronate.

R J Lieverse.   

Abstract

A 77 year-old woman developed severe hepatitis. No cause was found apart from alendronate medication. The hepatitis resolved after alendronate was stopped.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9883006     DOI： 10.1016/s0300-2977(98)00109-0

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


  5 in total

1.  Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.

Authors:  S A Polyzos; J Kountouras; A D Anastasilakis; I Litsas; M Kita; G Arsos; E Moralidis; E Terpos
Journal:  Osteoporos Int       Date:  2010-04-21       Impact factor: 4.507

Review 2.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

3.  Alendronate effect in esophagus, stomach and liver: an animal based pathological study.

Authors:  Theodora Papamitsou; Sotiris Sotiriou; Apostolos Papakoulas; Alexandros Toskas; Dimitrios Kamperis; Sofia Karachrysafi; Eva-Maria Dietrich; Stergios Lialiaris; Antonia Sioga
Journal:  Histol Histopathol       Date:  2019-09-10       Impact factor: 2.303

4.  Hepatotoxicity induced by alendronate therapy.

Authors:  B Yanik; C Turkay; H Atalar
Journal:  Osteoporos Int       Date:  2007-01-17       Impact factor: 5.071

5.  Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis.

Authors:  Yan Jiang; Yong Fu; Xiao-ping Xing; Mei Li; Ou Wang; Wei-bo Xia; Xun-wu Meng
Journal:  Eur J Med Res       Date:  2015-08-22       Impact factor: 2.175
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.